{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:20:35Z","timestamp":1793154035990,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004439","name":"William and Flora Hewlett Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.contraception.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T06:38:11Z","timestamp":1433659091000},"page":"206-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Continuing pregnancy after mifepristone and \u201creversal\u201d of first-trimester medical abortion: a systematic review"],"prefix":"10.1016","volume":"92","author":[{"given":"Daniel","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-7447","authenticated-orcid":false,"given":"Matthew","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.06.001_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.AOG.0000444454.67279.7d","article-title":"Practice Bulletin No 143: Medical management of first-trimester abortion","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0010","series-title":"Safe abortion: technical and policy guidance for health systems","year":"2012"},{"key":"10.1016\/j.contraception.2015.06.001_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.02.012","article-title":"Women's perceptions on medical abortion","volume":"74","author":"Ho","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1363\/46e0414","article-title":"Abortion incidence and service availability in the United States, 2011","volume":"46","author":"Jones","year":"2014","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2015.06.001_bb0035","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1345\/aph.1R252","article-title":"Progesterone use to reverse the effects of mifepristone","volume":"46","author":"Delgado","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.contraception.2015.06.001_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0010-7824(86)90055-7","article-title":"Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost)","volume":"34","author":"Cameron","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0010-7824(88)90080-7","article-title":"The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens","volume":"38","author":"Birgerson","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(88)90361-4","article-title":"Early abortion with a single dose of the antiprogestin RU-486","volume":"158","author":"Grimes","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(84)90014-3","article-title":"Termination of very early pregnancy by RU 486 \u2014 an antiprogestational compound","volume":"29","author":"Kovacs","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000293291","article-title":"Induction of abortion in early pregnancy with mifepristone","volume":"29","author":"Somell","year":"1990","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.contraception.2015.06.001_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.humrep.a136838","article-title":"Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy","volume":"4","author":"Swahn","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2015.06.001_bb0070","first-page":"653","article-title":"Outpatient therapeutic abortion with mifepristone","volume":"74","author":"Ylikorkala","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0075","first-page":"19","article-title":"RU 486 (mifepristone): clinical trials in China","volume":"149","author":"Zheng","year":"1989","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.contraception.2015.06.001_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0028-2243(88)90035-4","article-title":"Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist","volume":"28","author":"Maria","year":"1988","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0085","first-page":"1325","article-title":"Experiences with the antigestagen mifepristone (RU 486) in the interruption of early pregnancy","volume":"111","author":"Carol","year":"1989","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0090","first-page":"1089","article-title":"Early pregnancy interruption using an antiprogesterone steroid: mifepristone (RU 486)","volume":"17","author":"Maria","year":"1988","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.contraception.2015.06.001_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2008.07.015","article-title":"Medical abortion practices: a survey of National Abortion Federation members in the United States","volume":"78","author":"Wiegerinck","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.06.001_bb0105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/AOG.0000000000000276","article-title":"Identification of candidates for progesterone: why, who, how, and when?","volume":"123","author":"Iams","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.06.001_bb0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.fertnstert.2008.02.012","article-title":"Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: an educational bulletin","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2015.06.001_bb0115","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.06.001_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-4731(87)90083-5","article-title":"Plasma concentrations and receptor binding of RU 486 and its metabolites in humans","volume":"26","author":"Heikinheimo","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2015.06.001_bb0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.contraception.2015.02.026","article-title":"Medical abortion outcomes following quickstart of contraceptive implants","volume":"91","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.contraception.2013.07.008","article-title":"Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study","volume":"88","author":"Sonalkar","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0010-7824(03)00171-9","article-title":"Pharmacological properties of mifepristone: toxicology and safety in animal and human studies","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.06.001_bb0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2015.06.001_bb0145","series-title":"Code of Federal Regulations, 45 CFR 46.102 (d)","year":"2009"},{"key":"10.1016\/j.contraception.2015.06.001_bb0150","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMsb1209858","article-title":"Legislative interference with the patient\u2013physician relationship","volume":"367","author":"Weinberger","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415002267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415002267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T21:23:26Z","timestamp":1537565006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415002267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0010782415002267"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.06.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuing pregnancy after mifepristone and \u201creversal\u201d of first-trimester medical abortion: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}